Viewing SEC Facts Units
Company Name:
Regulus Therapeutics Inc.
CIK:
1505512
Start Filing Date:
2017-04-01
End Filing Date:
2017-06-30
ACCN:
0001628280-17-007796
Value:
$ 53,182,330
Value Error:
$ None
Created By:
Date Filed:
2017-08-02
FY:
2017
Fiscal Period:
Q2
Frame:
CY2016Q2
Type:
us-gaap
Form:
10-Q
Units:
shares